Belimumab (Benlysta▼): increased risk of serious psychiatric events seen in clinical trials

2019-04-16T15:53:56+01:00

Clinical trials, including interim findings from a randomised trial, show an increased risk of depression, suicidal ideation or behaviour, or self-injury in patients with systemic lupus erythematosus receiving belimumab comp…